Description:-
Type 1 Diabetes and Type 2 Diabetes are common types of diabetes. Treatments include (1) agents that increase the amount of insulin secreted by the pancreas, (2) agents that increase the sensitivity of target organs to insulin, and (3) agents that decrease the rate at which glucose is absorbed from the gastrointestinal tract.
Scope of the Report:
This report focuses on the Antidiabetics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The North American antidiabetics market held the largest market revenue share in 2013. High market penetration of modern insulin products such as long-acting, rapid acting insulin analogs and DPP-4 drugs such as Januvia, Onglyza and Nesina and the presence of high healthcare expenditures, patient awareness levels, sophisticated healthcare infrastructure and reimbursement framework are the major factors contributing to its large share.
Asia Pacific on account of the rapidly improving healthcare expenditure levels, growing prevalence of type I and type II diabetes and increasing patient disposable incomes is expected to grow at the fastest rate during the forecast period.
Get a Sample Report@ https://www.wiseguyreports.com/sample-request/3370701-global-antidiabetics-market-2018-by-manufacturers-regions-type
For more information or any query mail at sales@wiseguyreports.com
The worldwide market for Antidiabetics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Sanofi-Aventis
Takeda Pharmaceuticals
Eli Lilly
Oramed Pharmaceuticals
Boehringer Ingelheim
Merck & Co. Inc.
Novo Nordisk
Bristol-Myers Squibb
Halozyme Therapeutics
Pfizer
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Type 1 Diabetes
Type 2 Diabetes
Other
Market Segment by Applications, can be divided into
Hospital Use
Clinic Use
Household
Other
There are 15 Chapters to deeply display the global Antidiabetics market.
Chapter 1, to describe Antidiabetics Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Antidiabetics, with sales, revenue, and price of Antidiabetics, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Antidiabetics, for each region, from 2013 to 2018;
Continued……
Enquiry About Report @ https://www.wiseguyreports.com/enquiry/3370701-global-antidiabetics-market-2018-by-manufacturers-regions-type
Table Of Contents – Major Key Points
1 Market Overview
1.1 Antidiabetics Introduction
1.2 Market Analysis by Type
1.2.1 Type 1 Diabetes
1.2.2 Type 2 Diabetes
1.2.3 Other
1.3 Market Analysis by Applications
1.3.1 Hospital Use
1.3.2 Clinic Use
1.3.3 Household
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi-Aventis
2.1.1 Business Overview
2.1.2 Antidiabetics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Sanofi-Aventis Antidiabetics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Takeda Pharmaceuticals
2.2.1 Business Overview
2.2.2 Antidiabetics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Takeda Pharmaceuticals Antidiabetics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Eli Lilly
2.3.1 Business Overview
2.3.2 Antidiabetics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Eli Lilly Antidiabetics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Oramed Pharmaceuticals
2.4.1 Business Overview
2.4.2 Antidiabetics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Oramed Pharmaceuticals Antidiabetics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Boehringer Ingelheim
2.5.1 Business Overview
2.5.2 Antidiabetics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Boehringer Ingelheim Antidiabetics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Merck & Co. Inc.
2.6.1 Business Overview
2.6.2 Antidiabetics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Merck & Co. Inc. Antidiabetics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Novo Nordisk
2.7.1 Business Overview
2.7.2 Antidiabetics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Novo Nordisk Antidiabetics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Continued……
Buy 1-user PDF @https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3370701
For more information or any query mail at sales@wiseguyreports.com
ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.
Media Contact
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India
Website: www.wiseguyreports.com